ABBVIE INC.
ABBV XNYS
$201.55
-1.16 (-0.57%)
▼
15-min delayed
Open
$201.92
High
$202.40
Low
$200.02
Volume
4.92M
Market Cap
$356.49B
About ABBVIE INC.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Key Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| TTM 2025 | $61.16B | $4.23B | $2.37 |
| FY 2025 | $61.16B | $4.23B | $2.37 |
| Q3 2025 | $15.78B | $188.00M | $0.10 |
| Q2 2025 | $15.42B | $941.00M | $0.52 |
TickerDaily Coverage
Stock Market Today, April 20, 2026: S&P 500 Closes Flat as Tech Weighs on Gains
Market News
Sarah Mitchell · Apr 20, 2026
The stock market today finished mixed on Monday, April 20, 2026, with the S&P 500 essentially flat...
Stock Market Today, April 19, 2026: Earnings Week Ahead Shapes Trading Strategy
Market News
David Brooks · Apr 20, 2026
With mega-cap earnings dominating next week's calendar, the stock market today sets up for a...
Healthcare Stocks This Week: XLV Ends Mixed as Pharma Giants Face Margin Pressures (Mar 23–27, 2026)
Market News
David Brooks · Mar 27, 2026
The healthcare sector finished Friday, March 27, 2026 in neutral territory as investor focus...
Stock Market Today, March 24, 2026: S&P 500 Opens Higher on Jobs Data, Tech Leads Rally
Market News
Sarah Mitchell · Mar 24, 2026
The S&P 500 opened Tuesday, March 24, 2026 with solid gains as investors digested...
Stock Market Today: S&P 500 Closes Higher on Soft Inflation Data
Market News
Sarah Mitchell · Feb 24, 2026
U.S. equities finished mixed Tuesday as investors digested softer-than-expected inflation readings,...
View All Coverage →
Get ABBV Alerts
Stay ahead with breaking news, price alerts, and expert analysis on ABBVIE INC..
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.